Browse > Article
http://dx.doi.org/10.4062/biomolther.2016.137

Intravenous Administration of Substance P Attenuates Mechanical Allodynia Following Nerve Injury by Regulating Neuropathic Pain-Related Factors  

Chung, Eunkyung (BIO R&D Center, L&K BIOMED CO., LTD.)
Yoon, Tae Gyoon (Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Research Institute of Medical Science, Konkuk University School of Medicine)
Kim, Sumin (Department of Genetic Engineering, College of Life Science and Graduate School of Biotechnology, Kyung Hee University)
Kang, Moonkyu (Department of Dental Anesthesiology and Dental Research Institute, School of Dentistry, Seoul National University)
Kim, Hyun Jeong (Department of Dental Anesthesiology and Dental Research Institute, School of Dentistry, Seoul National University)
Son, Youngsook (Department of Genetic Engineering, College of Life Science and Graduate School of Biotechnology, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.25, no.3, 2017 , pp. 259-265 More about this Journal
Abstract
This study aimed to investigate the analgesic effect of substance P (SP) in an animal model of neuropathic pain. An experimental model of neuropathic pain, the chronic constriction injury (CCI) model, was established using ICR mice. An intravenous (i.v.) injection of SP (1 nmole/kg) was administered to the mice to examine the analgesic effects of systemic SP on neuropathic pain. Behavioral testing and immunostaining was performed following treatment of the CCI model with SP. SP attenuated mechanical allodynia in a time-dependent manner, beginning at 1 h following administration, peaking at 1 day post-injection, and decaying by 3 days post-injection. The second injection of SP also increased the threshold of mechanical allodynia, with the effects peaking on day 1 and decaying by day 3. A reduction in phospho-ERK and glial fibrillary acidic protein (GFAP) accompanied the attenuation of mechanical allodynia. We have shown for the first time that i.v. administration of substance P attenuated mechanical allodynia in the maintenance phase of neuropathic pain using von Frey's test, and simultaneously reduced levels of phospho-ERK and GFAP, which are representative biochemical markers of neuropathic pain. Importantly, glial cells in the dorsal horn of the spinal cord (L4-L5) of SP-treated CCI mice, expressed the anti-inflammatory cytokine, IL-10, which was not seen in vehicle saline-treated mice. Thus, i.v. administration of substance P may be beneficial for improving the treatment of patients with neuropathic pain, since it decreases the activity of nociceptive factors and increases the expression of anti-nociceptive factors.
Keywords
Mechanical allodynia; GFAP; IL-10; Neuropathic pain; Substance P; Glial inactivation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Austin, P. J. and Moalem-Taylor, G. (2010) The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26-50.   DOI
2 Bradesi, S. (2010) Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol. Motil. 22, 499-511.   DOI
3 Chen, W. L., Zhang, Y. Q. and Zhao, Z. Q. (2006) Neurokinin-1 receptor in peripheral nerve terminals mediates thermal hyperalgesia. Biochem. Biophys. Res. Commun. 339, 132-136.   DOI
4 Dong, X. G. and Yu, L. C. (2005) Alterations in the substance P-induced anti-nociception in the central nervous system of rats after morphine tolerance. Neurosci. Lett. 381, 47-50.   DOI
5 Gao, Y. J., Zhang, Y. Q. and Zhao, J. Q. (2003) Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat. Brain Res. Bull. 61, 587-593.   DOI
6 Gao, Y. J. and Ji, R. R. (2010) Targeting astrocyte signaling for chronic pain. Neurotherapeutics 7, 482-493.   DOI
7 Muto, Y., Sakai, A., Sakamoto, A. and Suzuki, H. (2012) Activation of NK1 receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain. Br. J. Pharmacol. 166, 1047-1057.   DOI
8 Nakayama, T., Naono, R., Ikeda, T. and Nishimori, T. (2010) NMDA and AMPA receptors contribute to the maintenance of substance P-induced thermal hyperalgesia. Neurosci. Res. 67, 18-24.   DOI
9 Nichols, M. L., Allen, B. J., Rogers, S. D., Ghilardi, J. R., Honore, P., Luger, N. M., Pinke, M. P., Li, J., Lappi, D. A., Simone, D. A. and Mantyh, P. W. (1999) Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286, 1558-1561.   DOI
10 Pailleux, F., Lemoine, J. and Beaudry, F. (2013) Investigation of the metabolic biotransformation of substance P in liver microsomes by liquid chromatography quadrupole ion trap mass spectrometry. Biomed. Chromatogr. 27, 39-47.   DOI
11 Parenti, C., Arico, G., Ronsisvalle, G. and Scoto, G. M. (2012) Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain. Peptides 34, 412-418.   DOI
12 Parris, W. C. V., Kambam, J. R., Naukam, R. J. and Rama Sastry, B. V. (1990) Immunoreactive substance P is decreased in saliva of patients with chronic back pain syndromes. Anesth. Analg. 70, 63-67.   DOI
13 Sahbaie, P., Shi, X., Guo, T. Z., Qiao, Y., Yeomans, D. C., Kingery, W. S. and Clark, J. D. (2009) Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 145, 341-349.   DOI
14 Shibata, K., Sugawara, T., Fujishita, K., Shinozaki, Y., Matsukawa, T., Suzuki, T. and Koizumi, S. (2011) The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS ONE 6, e23510.   DOI
15 Takeda, K., Sawamura, S., Sekiyama, H., Tamai, H. and Hanaoka, K. (2004) Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology 100, 1249-1257.   DOI
16 Holden, J. E., Pizzi, J. A. and Jeong, Y. (2009) An NK1 receptor antagonist microinjected into the periaqueductal gray blocks lateral hypothalamic-induced antinociception in rats. Neurosci. Lett. 453, 115-119.   DOI
17 Hong, H. S., Lee, J., Lee, E., Kwon, Y. S., Lee, E., Ahn, W., Jiang, M. H., Kim, J. C. and Son, Y. (2009) A new role of substance P as an injury-inducible messenger for mobilization of $CD29^+$ stromal-like cells. Nat. Med. 15, 425-435.   DOI
18 Ji, F. T., Liang, J. J., Liu, L., Cao, M. H. and Li, F. (2013) Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury. Chin. Med. J 126, 1125-1131.
19 Jiang, M. H., Chung, E., Chi, G. F., Ahn, W., Lim, J. E., Hong, H. S., Kim, D. W., Choi, H., Kim, J. and Son, Y. (2012) Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 23, 786-792.   DOI
20 Shimizu, K., Guo, W., Wang, H., Zou, S., LaGraize, S. C., Iwata, K., Wei, F., Dubner, R. and Ren, K. (2009) Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol. Pain 5, 75.
21 Traub, R. J. (1996) The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 67, 151-161.   DOI
22 Vissers, K. C., Geenen, F., Biermans, R. and Meert, T. F. (2006) Pharmacological correlation between the formalin test and the neuropathic pain behavior in different species with chronic constriction injury. Pharmacol. Biochem. Behav. 84, 479-486.   DOI
23 Wang, L. H., Zhou, S. X., Li, R. C., Zheng, L. R., Zhu, J. H., Hu, S. J. and Sun, Y. L. (2012) Serum levels of calcitonin gene-related peptide and substance P are decreased in patients with diabetes mellitus and coronary artery disease. J. Int. Med. Res. 40, 134-140.   DOI
24 Komatsu, T., Sasaki, M., Sanai, K., Kuwahata, H., Sakurada, C., Tsuzuki, M., Iwata, Y., Sakurada, S. and Sakurada, T. (2009) Intrathecal substance P auguments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. Peptides 30, 1689-1696.   DOI
25 Jiang, M. H., Lim, J. E., Chi, G. F., Ahn, W., Zhang, M., Chung, E. and Son Y. (2013) Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury. Neuroreport 24, 846-851.   DOI
26 Kanai, Y., Nakazato, E., Fujiuchi, A., Hara, T. and Imai, A. (2005) Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology 49, 977-984.   DOI
27 Kim, K. J., Yoon, Y. W. and Chung, J. M. (1997) Comparison of three rodent neuropathic pain models. Exp. Brain Res. 113, 200-206.   DOI
28 Komatsu, T., Mizoguchi, H., Sasaki, M., Sakurada, C., Tsuzuki, M., Sakurada, S. and Sakurada, T. (2011) Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response. Neuropharmacology 61, 608-613.   DOI
29 Ledeboer, A., Jekich, B. M., Sloane, E. M., Mahoney, J. H., Langer, S. J., Milligan, E. D., Martin, D., Maier, S. F., Johnson, K. W., Leinwand, L. A., Chavez, R. A. and Watkins, L. R. (2007) Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav. Immun. 21, 686-698.   DOI
30 Lee, J. Y., Shin, T. J., Choi, J. M., Seo, K. S., Kim, H. J., Yoon, T. G., Lee, Y. S., Han, H., Chung, H. J., Oh, Y., Jung, S. J. and Shin, K. J. (2013) Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice. Br. J. Anaesth. 111, 667-672.   DOI
31 Lee, M. J., Shin, T. J., Lee, J. E., Choo, H., Koh, H. Y., Chung, H. J., Pae, A. N., Lee, S. C. and Kim, H. J. (2010) KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models. Pharmacol. Biochem. Behav. 97, 198-204.   DOI
32 Lee, W. H., Shin, T. J., Kim, H. J., Lee, J. K., Suh, H. W., Lee, S. C. and Seo, K. (2011) Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice. Anesth. Analg. 112, 228-235.   DOI
33 Li, W. W., Guo, T. Z., Liang, D. Y., Sun, Y., Kingery, W. S. and Clark J. D. (2012) Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology 116, 882-895.   DOI
34 Lin, C. C., Chen, W. N., Chen, C. J., Lin, Y. W., Zimmer, A. and Chen, C. C. (2012) An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc. Natl. Acad. Sci. U.S.A. 109, E76-E83.   DOI
35 Ma, W. and Quirion, R. (2005) The ERK/MAP pathway, as a target for the treatment of neuropathic pain. Expert Opin. Ther. Targets 9, 699-713.   DOI
36 Mika, J., Zychowska, M., Popiolek-Barczyk, K., Rojewska, E. and Przewlocka, B. (2013) Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 716, 106-119.   DOI
37 Milligan, E. D. and Watkins, L. R. (2009) Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10, 23-36.   DOI
38 Andoh, T., Nagasawa, T., Satoh, M. and Kuraishi, Y. (1998) Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286, 1140-1145.